Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, 13) is vital for hemostasis, cleaving von Willebrand factor.
• Deficiency in ADAMTS13 activity can lead to thrombotic thrombocytopenic purpura, a serious blood disorder.
• ADAMTS13 undergoes various posttranslational modifications, including arginine methylation.

Purpose of the Study:

• To investigate the impact of arginine methylation by PRMT1 (protein arginine methyltransferase 1) on ADAMTS13 secretion and enzymatic function.
• To elucidate the role of specific methylation sites in ADAMTS13 activity.

Main Methods:

• Utilized cell culture (HEK-293 cells), recombinant protein expression, biochemical analyses, site-directed mutagenesis, and animal models.
• Employed PRMT1 inhibitors and overexpression systems to study methylation effects.
• LC-MS/MS was used to identify arginine methylation sites on ADAMTS13.

Main Results:

• Inhibition of arginine methylation decreased ADAMTS13 secretion but increased its specific activity.
• PRMT1 overexpression increased ADAMTS13 secretion but reduced its specific activity.
• Site-directed mutagenesis identified R1206 as critical for ADAMTS13 function, with the R1206K variant showing a 4- to 5-fold increase in specific activity.

Conclusions:

• Arginine methylation is crucial for regulating ADAMTS13 secretion and function.
• Findings suggest a novel allosteric regulation mechanism for ADAMTS13, potentially offering therapeutic insights.
• The study highlights the importance of posttranslational modifications in controlling enzyme activity and secretion.